Firm became aware that professional samples of Ceramax are not meeting stability standards set for the product.
Source facts
Action
Oculus issued Medical Device Recall letters dated November 21, 2016, to Sales reps notifying them to stop all further distribution and immediately remove the affected lots of Recall product from sample inventory. Customers were also instructed to sign the Response form verifying receipt of the letter. Customers with questions were instructed to call Oculus Innovative Science-Regulatory Affairs at 707-559-7181. For questions regarding this recall call 559-7191.
Initiated
2016-11-21
Root cause
Packaging process control
Terminated
2017-06-13
Distribution
Nationwide Distribution
Recall number
Z-0763-2017
Recall status
Terminated
CDRH record ID
151214
FDA classified
2016-12-14
Recall event number
75770
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.